Free Trial

Indivior (INDV) Competitors

Indivior logo
GBX 1,128 -17.00 (-1.48%)
As of 07/8/2025 11:48 AM Eastern

INDV vs. ITH, SOPH, HCM, GRI, SLS, ERGO, SLN, AMYT, BMY, and OGN

Should you be buying Indivior stock or one of its competitors? The main competitors of Indivior include Ithaca Energy (ITH), Sophos Group plc (SOPH.L) (SOPH), HUTCHMED (HCM), Grainger (GRI), Standard Life UK Smaller Companies Trust (SLS), Ergomed (ERGO), Silence Therapeutics (SLN), Amryt Pharma (AMYT), Bloomsbury Publishing (BMY), and Origin Enterprises (OGN). These companies are all part of the "pharmaceutical products" industry.

Indivior vs. Its Competitors

Indivior (LON:INDV) and Ithaca Energy (LON:ITH) are both pharmaceutical products companies, but which is the better business? We will compare the two businesses based on the strength of their valuation, risk, earnings, profitability, media sentiment, institutional ownership, dividends and analyst recommendations.

Indivior pays an annual dividend of GBX 15 per share and has a dividend yield of 1.3%. Ithaca Energy pays an annual dividend of GBX 28 per share and has a dividend yield of 17.5%. Indivior pays out -1,243.7% of its earnings in the form of a dividend. Ithaca Energy pays out 319.8% of its earnings in the form of a dividend, suggesting it may not have sufficient earnings to cover its dividend payment in the future.

Indivior currently has a consensus price target of GBX 1,650, suggesting a potential upside of 46.28%. Given Indivior's stronger consensus rating and higher probable upside, equities analysts clearly believe Indivior is more favorable than Ithaca Energy.

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Indivior
0 Sell rating(s)
0 Hold rating(s)
2 Buy rating(s)
0 Strong Buy rating(s)
3.00
Ithaca Energy
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
0.00

Ithaca Energy has higher revenue and earnings than Indivior. Indivior is trading at a lower price-to-earnings ratio than Ithaca Energy, indicating that it is currently the more affordable of the two stocks.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Indivior£1.40B1.26-£2.36M-£1.21-935.27
Ithaca Energy£3.55B0.94£230.29M£8.7618.29

Ithaca Energy has a net margin of 6.48% compared to Indivior's net margin of -0.17%. Ithaca Energy's return on equity of 4.55% beat Indivior's return on equity.

Company Net Margins Return on Equity Return on Assets
Indivior-0.17% -0.77% 2.37%
Ithaca Energy 6.48%4.55%0.18%

86.0% of Indivior shares are owned by institutional investors. Comparatively, 3.7% of Ithaca Energy shares are owned by institutional investors. 3.4% of Indivior shares are owned by insiders. Comparatively, 89.6% of Ithaca Energy shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

In the previous week, Ithaca Energy had 7 more articles in the media than Indivior. MarketBeat recorded 7 mentions for Ithaca Energy and 0 mentions for Indivior. Indivior's average media sentiment score of 0.25 beat Ithaca Energy's score of 0.15 indicating that Indivior is being referred to more favorably in the media.

Company Overall Sentiment
Indivior Neutral
Ithaca Energy Neutral

Summary

Ithaca Energy beats Indivior on 9 of the 17 factors compared between the two stocks.

Get Indivior News Delivered to You Automatically

Sign up to receive the latest news and ratings for INDV and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INDV and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

INDV vs. The Competition

MetricIndiviorDrug Manufacturers IndustryMedical SectorLON Exchange
Market Cap£1.76B£2.14B£5.47B£2.97B
Dividend Yield4.48%2.92%5.25%5.02%
P/E Ratio-935.274.1527.00150.92
Price / Sales1.26584.90435.75244,729.07
Price / Cash2.6810.3536.8227.97
Price / Book-8.9211.777.984.56
Net Income-£2.36M£21.15B£3.16B£5.90B
7 Day Performance0.71%1.71%2.40%1.62%
1 Month Performance11.13%6.38%2.19%4.25%
1 Year Performance49.11%4.16%33.82%79.63%

Indivior Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
INDV
Indivior
2.9126 of 5 stars
GBX 1,128
-1.5%
GBX 1,650
+46.3%
-4.3%£1.76B£1.40B-935.271,000Gap Up
ITH
Ithaca Energy
N/AGBX 157
-0.4%
N/A+30.5%£3.27B£3.55B17.93220News Coverage
SOPH
Sophos Group plc (SOPH.L)
N/AN/AN/AN/A£2.99B£726.90M341.41520
HCM
HUTCHMED
N/AGBX 221.81
-2.3%
N/A-11.3%£2.41B£771.01M-56.611,760
GRI
Grainger
3.6554 of 5 stars
GBX 221.50
+0.7%
GBX 317.50
+43.3%
-13.5%£1.64B£276.05M-1,476.67372Dividend Increase
SLS
Standard Life UK Smaller Companies Trust
N/AN/AN/AN/A£715.41M£222.48M3.3710
ERGO
Ergomed
N/AN/AN/AN/A£701.00M£152.09M4,641.386
SLN
Silence Therapeutics
N/AN/AN/AN/A£480.35M£11.35M-11.01100High Trading Volume
AMYT
Amryt Pharma
N/AN/AN/AN/A£457.11M£210.24M-4.33290Gap Down
BMY
Bloomsbury Publishing
2.981 of 5 stars
GBX 504
-1.6%
GBX 825
+63.7%
-25.2%£406.69M£382.40M10.7834,300
OGN
Origin Enterprises
N/AGBX 3.68
flat
N/A+17.8%£388.03M£183.08B10.6310,000Dividend Increase

Related Companies and Tools


This page (LON:INDV) was last updated on 7/9/2025 by MarketBeat.com Staff
From Our Partners